title: Debate: PRO Position. Should hemoglobin targets for anemic patients with chronic kidney disease be changed?
authors.affiliation: Brigham and Women's Hospital and Harvard Medical School, Boston, Mass., USA. asingh@partners.org
authors.forename: Ajay K
authors.initials: AK
authors.lastname: Singh
mesh_terms: D000740:Anemia / Q000188:drug therapy* / Q000209:etiology*; D002908:Chronic Disease; D006397:Hematinics / Q000009:adverse effects / Q000627:therapeutic use*; D006454:Hemoglobins / Q000032:analysis*; D006801:Humans; D007674:Kidney Diseases / Q000150:complications*; D016896:Treatment Outcome
chemical_list: D006397:Hematinics; D006454:Hemoglobins